Admission to Standard Listing on the Official List of the FCA and to trading on the Main Market of the London Stock Exchange

17 July 2018

17 July 2018

OKYO Pharma Limited

(Incorporated and registered in Guernsey with registered number 65220)

 

Admission to Standard Listing on the Official List of the FCA and to trading on the Main Market of the London Stock Exchange

 

OKYO Pharma Limited (the “Company”) announces that its entire issued share capital of 523,395,417 ordinary shares of no par value each (the “Ordinary Shares”) has today been admitted to listing on the standard segment of the Official List of the Financial Conduct Authority (“FCA”) and to trading on the main market for listed securities of the London Stock Exchange plc (“Admission”).

 

The Ordinary Shares are registered with ISIN GG00BD3FV870, SEDOL BD3FV87 and TIDM OKYO, and the Company’s LEI is 213800VVN5CB56Y15A05.

 

 The total number of Ordinary Shares in the Company in issue immediately following Admission is 523,595,417 each with equal voting rights. This total voting rights figure of 523,595,417 can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure Guidance and Transparency Rules of the FCA.

 

Enquiries:

OKYO Pharma Limited                                             Willy Simon         +44 (0)20 7495 2379

Stockdale Securities Limited (Broker)                      Andy Crossley      +44 (0)20 7601 6100

                                                                              Antonio Bossi

                                                                              Owen Matthews

 

For further information, please visit the Company's website at http://okyopharma.com/.